agilon health, inc. Basic Shares Outstanding (Weighted Average)
agilon health, inc. (AGL) reported Basic Shares Outstanding (Weighted Average) of 16.70 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- agilon health, inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 16.70M shares, a 0.92% increase year-over-year.
- agilon health, inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 16.60M shares, a 0.50% increase year-over-year.
- agilon health, inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 414.62M shares, a 0.62% increase year-over-year.
- agilon health, inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 414.46M shares, a 0.70% increase year-over-year.
- agilon health, inc. weighted average number of shares outstanding, basic for fiscal 2025 was 413.97M shares, a 0.73% increase from fiscal 2024.
- agilon health, inc. weighted average number of shares outstanding, basic for fiscal 2024 was 410.97M shares, a 0.50% increase from fiscal 2023.
- agilon health, inc. weighted average number of shares outstanding, basic for fiscal 2023 was 408.92M shares, a 0.19% increase from fiscal 2022.
- agilon health, inc. weighted average number of shares outstanding, basic for fiscal 2022 was 408.15M shares, a 9.44% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 16.70M shares 10-Q · filed 2026-08-05 | 16.65M shares 10-Q · filed 2026-08-05 | 149.31M shares derived: average of 3 quarters · filed 2026-08-05 | 215.60M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | 16.60M shares 10-Q · filed 2026-05-06 | 215.61M shares derived: average of 2 quarters · filed 2026-05-06 | 281.90M shares derived: average of 3 quarters · filed 2026-05-06 | 215.56M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | 414.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 414.54M shares derived: average of 2 quarters · filed 2026-02-25 | 281.88M shares derived: average of 3 quarters · filed 2026-08-05 | 413.97M shares 10-K · filed 2026-02-25 | ||
| 2025-09-30 | 414.46M shares 10-Q · filed 2025-11-04 | 215.51M shares derived: average of 2 quarters · filed 2026-08-05 | 413.75M shares 10-Q · filed 2025-11-04 | 214.90M shares derived: average of 4 quarters · filed 2026-08-05 | ||
| 2025-06-30 | 16.55M shares 10-Q · filed 2026-08-05 | 413.84M shares 10-Q · filed 2025-08-04 | 16.54M shares 10-Q · filed 2026-08-05 | 413.39M shares 10-Q · filed 2025-08-04 | 148.37M shares derived: average of 3 quarters · filed 2026-08-05 | 214.18M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 16.52M shares 10-Q · filed 2026-05-06 | 412.94M shares 10-Q · filed 2025-05-06 | 214.28M shares derived: average of 2 quarters · filed 2026-05-06 | 280.05M shares derived: average of 3 quarters · filed 2026-05-06 | 312.86M shares derived: average of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | 412.05M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 411.82M shares derived: average of 2 quarters · filed 2026-02-25 | 411.64M shares derived: average of 3 quarters · filed 2026-02-25 | 410.97M shares 10-K · filed 2026-02-25 | ||
| 2024-09-30 | 411.59M shares 10-Q · filed 2025-11-04 | 411.43M shares derived: average of 2 quarters · filed 2025-11-04 | 410.60M shares 10-Q · filed 2025-11-04 | 407.81M shares derived: average of 4 quarters · filed 2026-02-25 | ||
| 2024-06-30 | 411.27M shares 10-Q · filed 2025-08-04 | 409.15M shares 10-Q · filed 2025-08-04 | 406.55M shares derived: average of 3 quarters · filed 2026-02-25 | 406.36M shares derived: average of 4 quarters · filed 2026-02-25 | ||
| 2024-03-31 | 408.94M shares 10-Q · filed 2025-05-06 | 404.19M shares derived: average of 2 quarters · filed 2026-02-25 | 404.72M shares derived: average of 3 quarters · filed 2026-02-25 | 406.13M shares derived: average of 4 quarters · filed 2026-02-25 | ||
| 2023-12-31 | 399.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 402.61M shares derived: average of 2 quarters · filed 2026-02-25 | 405.19M shares derived: average of 3 quarters · filed 2026-02-25 | 408.92M shares 10-K · filed 2026-02-25 | ||
| 2023-09-30 | 405.79M shares 10-Q · filed 2024-11-07 | 408.06M shares derived: average of 2 quarters · filed 2024-11-07 | 412.08M shares 10-Q · filed 2024-11-07 | 410.35M shares derived: average of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | 410.34M shares 10-Q · filed 2024-08-06 | 411.75M shares 10-Q · filed 2024-08-06 | 411.87M shares derived: average of 3 quarters · filed 2025-02-25 | 411.67M shares derived: average of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | 413.14M shares 10-Q · filed 2024-05-07 | 412.64M shares derived: average of 2 quarters · filed 2025-02-25 | 412.12M shares derived: average of 3 quarters · filed 2025-02-25 | 410.92M shares derived: average of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | 412.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 411.61M shares derived: average of 2 quarters · filed 2025-02-25 | 410.18M shares derived: average of 3 quarters · filed 2025-02-25 | 408.15M shares 10-K · filed 2025-02-25 | ||
| 2022-09-30 | 411.06M shares 10-Q · filed 2023-11-02 | 409.20M shares derived: average of 2 quarters · filed 2023-11-02 | 406.82M shares 10-Q · filed 2023-11-02 | 404.26M shares derived: average of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | 407.34M shares 10-Q · filed 2023-08-03 | 404.67M shares 10-Q · filed 2023-08-03 | 401.99M shares derived: average of 3 quarters · filed 2024-02-27 | 399.30M shares derived: average of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | 401.96M shares 10-Q · filed 2023-05-09 | 399.32M shares derived: average of 2 quarters · filed 2024-02-27 | 396.62M shares derived: average of 3 quarters · filed 2024-02-27 | 391.83M shares derived: average of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | 396.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 393.95M shares derived: average of 2 quarters · filed 2024-02-27 | 388.45M shares derived: average of 3 quarters · filed 2024-02-27 | 372.93M shares 10-K · filed 2024-02-27 | ||
| 2021-09-30 | 391.23M shares 10-Q · filed 2022-11-03 | 384.34M shares derived: average of 2 quarters · filed 2022-11-03 | 365.02M shares 10-Q · filed 2022-11-03 | |||
| 2021-06-30 | 377.44M shares 10-Q · filed 2022-08-04 | 351.69M shares 10-Q · filed 2022-08-04 | ||||
| 2021-03-31 | 325.66M shares 10-Q · filed 2022-05-05 | |||||
| 2020-12-31 | 323.46M shares 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |